LBP AM’s Teva Pharmaceuticals TEVA Stock Holding History

LBP AM’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-76,265	Closed	-$1.24M	–	407
2024 Q2	$1.24M	Buy	+76,265	New	+$1.17M	0.05%	194

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

LBP AM's TEVA Position: Q3 2024 in Review

LBP AM sold out of Teva Pharmaceuticals (TEVA) in Q3 2024, closing a stake of 76,265 shares — an estimated $1.24M sold.

LBP AM first reported a position in TEVA in Q2 2024 and held it in 1 quarter. The position peaked at $1.24M in Q2 2024. 542 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

LBP AM reported no remaining Teva Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
LBP AM sold 76,265 Teva Pharmaceuticals shares in Q3 2024, an estimated $1.24M.
LBP AM first reported a position in Teva Pharmaceuticals in Q2 2024 and held it in 1 quarter.
LBP AM's Teva Pharmaceuticals position peaked at $1.24M in Q2 2024.
542 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2024.

Based on LBP AM's 13F filing for Q3 2024, filed 12 Nov 2024.